MUM1 Expression versus Hans Algorithm to Predict Prognosis in Indonesian Diffuse Large B-Cell Lymphoma Patients Receiving R-CHOP.
Cosphiadi IrawanMartha IskandarAgnes Stephanie HarahapCleopas Martin RumendeMaria Francisca HamPublished in: Cancer management and research (2022)
MUM1 expression of 50% or more can help predict prognosis in DLBCL patients receiving R-CHOP therapy and can be considered as for use as a single marker to predict prognosis.